4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-23-030092
CEO & Chief Scientific Officer acquired 115,684 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & Chief Scientific Officer | 2023-03-06 | Grant or award | +81,383 | 2,185,526 | D: show line 1 in the form | ||
| Zhang Jack Y. CEO & Chief Scientific Officer | 2023-03-06 | Grant or award | +34,301 | 1,532,820 | I: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & Chief Scientific Officer | 2023-03-06 | Grant or award · Employee Stock Option (right to buy) | +171,488 | 171,488 | D: show line 3 in the form | |||||
| Zhang Jack Y. CEO & Chief Scientific Officer | 2023-03-06 | Grant or award · Employee Stock Option (right to buy) | +72,278 | 72,278 | I: show line 4 in the form |
Loading xslF345X03/tm238753-1_4seq1.xml…